Your gift is 100% tax deductible.
Survival Rates for Brain Tumors in Children
Survival rates are a way to measure how many people survive a certain type of cancer over time. They cannot tell you exactly what will happen with any one person, but they may help give you a better understanding of how likely it is that treatment will be successful.
What is a 5-year survival rate?
The 5-year survival rate refers to the percentage of people who live at least 5 years after their cancer is diagnosed. Of course, people may live much longer than 5 years (and many are cured).
To get 5-year survival rates, doctors must look at people who were treated at least 5 years ago. Changes in treatment since then may result in a better outlook for people diagnosed with a certain type of brain tumor today.
Your doctor can tell you how the survival rates below might apply to your situation.
Survival rates for more common brain tumors in children and young adults
The numbers below come from the Central Brain Tumor Registry of the United States (CBTRUS) and are based on children and young adults treated between 2015 and 2021. There are some important points to note about these numbers:
- These numbers are for some of the more common types of tumors. Numbers are not readily available for all types of tumors that occur in children, often because they are rare or hard to classify.
- In some cases, the numbers include a range of different tumors that can have different outlooks.
Type of Tumor |
5-Year Survival Rate |
|
|
0-14 years |
15-39 years |
Pilocytic astrocytoma |
97% |
95% |
Diffuse astrocytoma |
82% |
79% |
Anaplastic astrocytoma |
26% |
65% |
Glioblastoma |
20% |
29% |
Oligodendroglioma |
94% |
93% |
Ependymal tumors |
82% |
95% |
Medulloblastoma |
74% |
81% |
Atypical teratoid/rhabdoid tumor |
36% |
N/A |
Germ cell tumors |
88% |
90% |
Meningioma |
95% |
97% |
Survival rates are only estimates. Talk to your doctor to better understand your specific situation and how these numbers may apply to you.
- Written by
- References
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Price M, Ballard CAP, Benedetti JR, Kruchko C, Barnholtz-Sloan JS, Ostrom QT. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2018-2022. Neuro Oncol. 2025;27(Supplement_4):iv1-iv66.
Price M, Ryan K, Shoaf ML, et al. Childhood, adolescent, and adult primary brain and central nervous system tumor statistics for practicing healthcare providers in neuro-oncology, CBTRUS 2015-2019. Neurooncol Pract. 2023;11(1):5-25. Published 2023 Sep 28.
Last Revised: February 9, 2026
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
American Cancer Society Emails
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.


